Publications found:
37,044
Sort by:
Onyx Pharma - Banking on Carfilzomib’s Approval or Acquisition!
US$ 90.00
... Bayer for Japan royalties made FY11 a profitable year for Onyx pharma (ONXX), we do not expect it to be sustainable as high operating expenses (h43% YoY ... detail, please read our report released on 2nd Mar., 2012 on Onyx Pharma titled “Onyx Pharma - Banking on Carfilzomib’s Approval or Acquisition!”
March 2012
4 pages
Analyzing the Indian Pharmaceutical Industry
US$ 300.00
... which have already been committed to the Government of India. The Indian pharmaceutical industry has a unique amalgamation of three critical factors ... global drug producing nations. Aruvian's R'search’s report on Analyzing the Indian Pharmaceutical Industry is an extensive outlook on the industry which explains ...
March 2012
75 pages
Indian Pharmaceutical Industry – SWOT Framework Analysis
US$ 175.00
The Indian pharmaceutical industry is one of the fast growing sectors of the Indian economy and has made ... and become significant players in the international market. SWOT Analysis, is a strategic planning tool used to ... achieving that objective. The aim of any SWOT analysis is to identify the key internal and ...
March 2012
20 pages
Pharmaceutical Industry in India – PEST Framework Analysis
US$ 175.00
... like US and Europe. In the recent past, several pharmaceutical companies have demonstrated that they possess the ability to engage ... significant players in the international market. Aruvian's R'search analyzes the Pharmaceutical Industry in India in a PEST Framework Analysis. A PEST analysis is concerned with ...
March 2012
20 pages
Pharmaceutical Industry in India – Porter’s Five Forces Strategy Analysis
US$ 175.00
... markets like US and Europe. In the recent past, several pharmaceutical companies have demonstrated that they possess the ability to engage ... players in the international market. Aruvian's R'search analyzes The Pharmaceutical Industry in India in Michael Porter’s Five Forces Analysis. It uses concepts developed ...
March 2012
20 pages
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
US$ 3,995.00
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various ... the market for treatments in the future. It is a time of change for this market sector, with OTC product launches, rising skin cancer incidence and ...
February 2012
300 pages
Japan- Pharma Fact Sheet
US$ 400.00
Looking at the great deal of business interest in the Japan Pharmaceutical space, we have recently published a report on Japan Pharma - "Japan Pharma - Factsheet". The 10 page report has som...
February 2012
8 pages
China’s Guidebook for Pharmaceutical Patent Protection
US$ 1,495.00
Description China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB 1550 billion (about US...
February 2012
230 pages
Drug Industry in the United States - Porter’s Five Forces Strategy Analysis
US$ 175.00
... falling, leading to layoffs and cuts in research budgets. While the US drug industry is hardly in a full-blown crisis, however, layoffs are occurring ... taken once a week instead of daily. Aruvian's R'search analyzes the United States Drug Industry in the Michael Porter’s Five Forces Analysis. It uses concepts ...
February 2012
12 pages
Analyzing the Global Pharmaceutical Industry
US$ 450.00
... corporate enterprises. Aruvian's R'search’s report – Analyzing the Global Pharmaceutical Industry - presents a complete analysis of the global pharmaceutical industry by setting up a industry demarcation and ...
February 2012
480 pages
Pharmaceutical Industry in China
US$ 325.00
... the government in the industry, and investment opportunities in China’s Pharmaceutical Industry. Complete with a comprehensive section on the clinical ... players in the Chinese Pharmaceutical Industry, Aruvian’s latest research is a collection of all you need to know about China’s Pharmaceutical Industry.
February 2012
80 pages
Pharmaceutical Industry in China – PEST Framework Analysis
US$ 175.00
... manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and ... competitiveness, coupled with a lack of patented pharmaceuticals developed in-house. Aruvian's R'search analyzes Pharmaceutical Industry in China in a PEST Framework Analysis. A PEST ...
February 2012
25 pages
Pharmaceutical Industry in Mexico
US$ 325.00
... cellular and molecular levels to dramatically advance the treatment of disease. Mexico’s pharmaceutical policy environment is in a period of rapid evolution, with simultaneous policy development ...
February 2012
120 pages
Pharmaceutical Industry in Poland
US$ 300.00
... on healthcare as economies boomed globally. The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D ... of hospitalization. Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in Denmark. The report covers a brief profile of the global ...
February 2012
100 pages
Pharmaceutical Industry in Denmark
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Denmark. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Denmark – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Sweden
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Sweden. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Sweden – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Japan
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Japan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Japan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Spain
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Spain. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Spain – complete with a SWOT analysis of the leading companies in ...
February 2012
145 pages
Pharmaceutical Industry in South Korea
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in South Korea. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... competition in the industry, and the key players in the pharmaceutical industry in South Korea – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in the Netherlands
US$ 300.00
... . Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in The Netherlands. The report covers a brief profile of the global ... competition in the industry, and the key players in the pharmaceutical industry in the Netherlands – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Brazil
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Brazil. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Brazil – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Norway
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Norway. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Norway – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Taiwan
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Taiwan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Taiwan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Hungary
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Hungary. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Hungary – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Belgium
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Belgium. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Belgium – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Germany
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Germany. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Germany – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Russia
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Russia. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Russia – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Czech Republic
US$ 300.00
... complete analysis of the Pharmaceutical Industry in Czech Republic. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in Czech Republic – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in South Africa
US$ 300.00
... complete analysis of the Pharmaceutical Industry in South Africa. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in South Africa – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Italy
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Italy. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Italy – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Meeting KOL Needs: What Pharma Needs to Know
US$ 1,445.00
The role of the Key Opinion Leader (KOL) has changed over the past 30 years. And it's about to change again.Once viewed with suspicion by their non-consulting peers, clinicians are now considered less...
January 2012
108 pages
Outsourcing in Drug Development: The Contract Research (Clinical Trial ) Market
US$ 3,995.00
... can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to ... (AMC), Contract Research Organizations and Others. Main Drivers for Outsourcing in Drug Development How CROs are Meeting the Challenge of Patient Recruitment Discussion ...
January 2012
235 pages
Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
US$ 2,635.00
... presentations. You will find answers in our work. Revenue forecasts, market shares, developmental trends, discussions and interviews In the report you ... charts and four research interviews. Advantages of Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 for your work In particular, this study ...
January 2012
120 pages
China Chemical Pharmaceutical Industry Report, 2011
US$ 2,300.00
In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...
January 2012
112 pages
Academic Detailing: Pharma Fights Back
US$ 745.00
Ever since it was introduced three decades ago, academic detailing—which now increasingly uses pharma’s sales techniques to educate physicians—has posed a difficult issue for the industry. Governed by...
January 2012
35 pages
China Pharmaceutical Chain Industry Report, 2011
US$ 1,800.00
In China, the pharmaceutical circulation enterprises see relatively low profit margin due to many circulation links. By sales value, some 20% drugs are sold to consumers through pharmaceutical retail...
December 2011
76 pages
Pharmaceuticals: Market Research Report
US$ 1,995.00
... also recapitulates recent noteworthy mergers, acquisitions, and other strategic developments. The report briefly discusses the pharmaceutical market outlook across various markets worldwide. Regional markets extensively discussed in the report include the United States, Canada, Japan, China, Germany, South ...
December 2011
443 pages
Global Pharmaceutical & Biotechnology Outlook 2012
US$ 12,000.00
... strategic and long term investment decision making of senior management. Outlook-11’ has been tailored to deliver more meaningfully in the ... for the future, and their key milestones. The Global Pharmaceutical Model is changing. Major pharmaceutical companies continue to under-perform in a market constrained ...
December 2011
466 pages
Outlook 2012 - Japanese Pharma - Cautious Ideas to Seize Value in Happening 2012!
US$ 2,000.00
‘Japanese Pharma Top & Bottom Picks’. Our analysis suggests that 2012 is going to be a happening year for Japan Pharma on multiple fronts – while next layer of reform ... largely supporting generic companies, select innovators from Japan hold value in term of their R&D. 2012 will unfold much of this value and ...
December 2011
78 pages